Innovent Biologics has dosed the first subject in the Phase III HeriCare-Ovarian01 trial of IBI354 for treating PROC with ...

ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced abstracts detailing multiple preclinical programs have been accepted ...

The 4th World ADC Asia Summit is back, offering the most comprehensive platform for Asia’s rapidly growing ADC community. This summit brings together cutting-edge innovators from Asia alongside ...

Uncertainty over U.S. President Donald Trump's tariffs has helped plunge a Toronto medical technology company into bankruptcy ...

Mass layoffs and resignations at the federal government are prompting concerns that a disgruntled former employee may seek to ...

The Intelys Secure Network Aggregation Point is a multi-tenanted, secure network edge that operates on an 'as a service' ...

CIEN to unveil coherent optical and IMDD technologies at OFC 2025, boosting scalability and flexibility for cloud and AI-driven data center networks.

The world's leading computer brand, GIGABYTE, is bringing its high-performance pre-built gaming PC, AORUS SUPREME 5, to the ...

Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2024 and highlighted recent business progress.

SHANGHAI, March 24, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. (the "WuXi XDC" or the "Group", stock code: 2268.HK), a leading ...

New name reflects focus on accelerating portfolio of advanced ADC therapies with speed, agility and precision Upon closing of strategic transactions, cash expected ...